Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Akira Onishi, Maiko Kaizu, Iku Shirasugi, Tomoko Yagyu, Yo Ueda, Yoshitada Sakai, Yasushi Miura & Jun Saegusa. (2023) Demographic, Physical, and Psychological Determinants of Patient Experience with Subcutaneous Self-Injection in Patients with Rheumatoid Arthritis: Structural Equation Modeling Approach. Patient Preference and Adherence 17, pages 1551-1559.
Read now
Read now
Robert J. Connor, Renee Clift & David W. Kang. (2023) Identifying a predictive relationship between maximal flow rate and viscosity for subcutaneous administration of macromolecules with recombinant human hyaluronidase PH20 in a miniature pig model. Drug Delivery 30:1.
Read now
Read now
Nemanja Damjanov, Nana Kirvalidze, Nana Kurashvili, Fausto Berti, Matjaz Steiger, Joanna Sobierska, Eric Guenzi, Hendrik Otto, Abid Sattar, Halimu N. Haliduola, Elin Edwald & Heimo Stroissnig. (2023) Assessment of real-life patient handling experience of AVT02 administered subcutaneously via autoinjector in patients with moderate to severe active rheumatoid arthritis: an open-label, single-arm clinical trial, then an extension phase of AVT02 administered with a prefilled syringe. Expert Opinion on Biological Therapy 23:8, pages 781-789.
Read now
Read now
Andreas Schneider, Reto Jost, Christoph Jordi & Jakob Lange. (2023) Autoinjectors for large-volume subcutaneous drug delivery: a review of current research and future directions. Expert Opinion on Drug Delivery 20:6, pages 815-830.
Read now
Read now
Beate Bittner. (2023) Drug delivery improvements to enable a flexible care setting for monoclonal antibody medications in oncology - Analogue-based decision framework. Expert Opinion on Drug Delivery 20:4, pages 457-470.
Read now
Read now
Yan Wei, Jin Zhao, Jian Ming, Xuewu Zhang & Yingyao Chen. (2022) Patient Preference for Self-Injection Devices in Rheumatoid Arthritis: A Discrete Choice Experiment in China. Patient Preference and Adherence 16, pages 2387-2398.
Read now
Read now
Marty Coyne, Amy Rinaldi, Katherine Brigham, James Hawthorne, Dimos Katsaros, Morgan Perich, Nicholas Carrara, Flore Pericaud, Chris Franzese & Graham Jones. (2022) Impact of Routines and Rituals on Burden of Treatment, Patient Training, Cognitive Load, and Anxiety in Self-Injected Biologic Therapy. Patient Preference and Adherence 16, pages 2593-2607.
Read now
Read now
James Hawthorne, Dimos Katsaros, Amy Rinaldi, Katherine Brigham, Matthew D’Auria, Erika Bajars, Chris Franzese & Marty Coyne. (2022) The current paradigm for biologic initiation: a confirmatory quantitative analysis of self-injection training practices. Expert Opinion on Drug Delivery 19:6, pages 733-742.
Read now
Read now
Juan Aw, Hedley Griffiths, Jane Zochling, Alfred Lanzafame & Andrew Jordan. (2021) Usability of the Certolizumab Pegol Auto-Injection Device in Australian Patients with Chronic Rheumatic Diseases: Results from a Market Research Study. Patient Preference and Adherence 15, pages 1469-1476.
Read now
Read now
Saki Yoneda, Tetsuo Torisu & Susumu Uchiyama. (2021) Development of syringes and vials for delivery of biologics: current challenges and innovative solutions. Expert Opinion on Drug Delivery 18:4, pages 459-470.
Read now
Read now
E. Lynne Kelley, Richard H. Smith, Gillian Corcoran, Sandra Nygren, Mary V. Jacoski & Andrea Fernandes. (2021) Advances in subcutaneous injections: PRECISE II: a study of safety and subject preference for an innovative needle-free injection system. Drug Delivery 28:1, pages 1915-1922.
Read now
Read now
Jean-David Zeitoun & Yves Morvan. (2020) Patients’ Perceptions and Preferences Regarding Two Different Forms of Methotrexate Autoinjectors for Moderate to Severe Rheumatoid Arthritis: A European Crossover Survey. Patient Preference and Adherence 14, pages 2177-2185.
Read now
Read now
Jennifer Mead, Ryan Dammerman & Soeren Rasmussen. (2020) Patient Reported Ease-of-Use with a Disposable Autoinjector in Individuals with Migraine. Patient Preference and Adherence 14, pages 1137-1144.
Read now
Read now
Daljit Tatla, Irina Mountian, Boglarka Szegvari, Brenda VanLunen & Michael Schiff. (2020) A multicenter, open-label study to evaluate the safe and effective use of a new electromechanical auto-injection device for self-injection of certolizumab pegol. Expert Opinion on Drug Delivery 17:6, pages 855-862.
Read now
Read now
Bart P. H. Pouls, Lars E. Kristensen, Marianne Petersson, B. J. F. van den Bemt, Luca Ballerini, Richard Bruggraber, Henrik Karlen, Irina Mountian, Etienne van Bracht, Susanne Wiegratz & Tanja S. Jørgensen. (2020) A pilot study examining patient preference and satisfaction for ava®, a reusable electronic injection device to administer certolizumab pegol. Expert Opinion on Drug Delivery 17:5, pages 705-711.
Read now
Read now
Ronak Patel, Miten Mehta, Parag Pipalava, Meghana Dahiya, Inderjeet Singh & Vinu Jose. (2019) Insights into human factor studies conducted for US FDA-approved biological combination products. Expert Opinion on Drug Delivery 16:12, pages 1333-1353.
Read now
Read now
Articles from other publishers (40)
Naoual Dahmana, Pierre-Louis Destruel, Samantha Facchetti, Vanessa Braun, Vanessa Lebouc, Zana Marin, Sulabh Patel & Gregoire Schwach. (2023) Reversible protein complexes as a promising avenue for the development of high concentration formulations of biologics. International Journal of Pharmaceutics 648, pages 123616.
Crossref
Crossref
Jiun Ming Tan, Emily Reeve, Lauren Fraser, Susanna M. Proudman & Michael D. Wiese. (2023) Barriers and Enablers in the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping Review. Arthritis Care & Research 75:11, pages 2306-2315.
Crossref
Crossref
Marko Puzovic, Hana Morrissey & Patrick A. Ball. (2023) The Experience of Home Parenteral Therapy: A Thematic Analysis of Patient Interviews. Pharmacy 11:5, pages 133.
Crossref
Crossref
Beate Bittner, Manuel Sánchez-Félix, Dennis Lee, Athanas Koynov, Joshua Horvath, Felix Schumacher & Simon Matoori. (2023) Drug delivery breakthrough technologies – A perspective on clinical and societal impact. Journal of Controlled Release 360, pages 335-343.
Crossref
Crossref
Héctor Corominas, David Young, J. R. Fraser Cummings, Yoram Bouhnik, Alessandro Armuzzi, Diamant Thaci & Jihyun Kim. (2023) Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review. Clinical Drug Investigation 43:8, pages 579-593.
Crossref
Crossref
Makoto Ito, Masahiro Kamata, Takeko Ishikawa, Hideaki Uchida, Shoya Suzuki, Ryosuke Takeshima, Ayu Watanabe, Itsumi Mizukawa, Shota Egawa, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka & Yayoi Tada. (2023) Improvements in self‐confidence and satisfaction with self‐injection after introducing self‐injection of dupilumab in patients with atopic dermatitis. Journal of Cutaneous Immunology and Allergy.
Crossref
Crossref
Kyle Berman, Simon Moss, Barry Holden-Theunissen, Nobuhiko Satou, Kenji Okada, Mark Latymer & Attila Antalfy. (2023) Design Development of the SMARTCLIC®/CLICWISE® Injection Device for Self-Administered Subcutaneous Therapies: Findings from Usability and Human Factor Studies. Advances in Therapy 40:7, pages 3070-3086.
Crossref
Crossref
Rieke Alten, Simon Moss, Stefanie Hahne, Angela T. Muriset, David Gruben & Mark Latymer. (2023) High Usability and Applicability Ratings for the New SmartClic®/ClicWise® Injection Device: Evidence from a Health Care Professional Opinion Study. Rheumatology and Therapy 10:2, pages 477-487.
Crossref
Crossref
Edgar Akuffo-Addo, Theodora Udounwa, Jocelyn Chan & Laura Cauchi. (2022) Exploring Biologic Treatment Hesitancy Among Black and Indigenous Populations in Canada: a Review. Journal of Racial and Ethnic Health Disparities 10:2, pages 942-951.
Crossref
Crossref
Takuo Kubota, Noriyuki Namba, Hiroyuki Tanaka, Koji Muroya, Yasuo Imanishi, Yasuhiro Takeuchi, Masanori Kanematsu, Wei Sun, Yoshiki Seino & Keiichi Ozono. (2023) Self-Administration of Burosumab in Children and Adults with X-Linked Hypophosphataemia in Two Open-Label, Single-Arm Clinical Studies. Advances in Therapy 40:4, pages 1530-1545.
Crossref
Crossref
Lisa Pivato, C Battistutta, Federica Torni, Daniele Mengato, Francesca Temporin & Francesca Venturini. (2023) The PEPSIN project: design and validation of a self-administered questionnaire for the assessment of equivalence between pens and prefilled syringes in patients on subcutaneous biological drugs. European Journal of Hospital Pharmacy 30:2, pages e13-e13.
Crossref
Crossref
Lisa Pivato, Daniele Mengato, Federica Torni, Claudia Battistutta, Francesca Temporin & Francesca Venturini. (2023) Factors influencing the acceptability of different devices for subcutaneous drug delivery: a cross-sectional observational study from the patient’s point of view. European Journal of Hospital Pharmacy, pages ejhpharm-2022-003477.
Crossref
Crossref
Beate Bittner. (2023) Customer-centric product presentations for monoclonal antibodies. AAPS Open 9:1.
Crossref
Crossref
Wan-Hee Yoo, Young Mo Kang, Dong Wook Kim, Eun Ha Kang, Yeon-Ah Lee, Chang-Hee Suh, Yoon-Kyoung Sung, Sang-Hoon Lee, Dong-Ha Gu, Jiwon Lee & Jung-Yoon Choe. (2022) Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data. Rheumatology and Therapy.
Crossref
Crossref
Liese Barbier, Yannick Vandenplas, Niels Boone, Isabelle Huys, Rob Janknegt & Arnold G Vulto. (2022) How to select a best-value biological medicine? A practical model to support hospital pharmacists. American Journal of Health-System Pharmacy 79:22, pages 2001-2011.
Crossref
Crossref
Richard L Wasserman, Charlotte Cunningham-Rundles, John Anderson, Patricia Lugar, Michael Palumbo, Niraj C Patel, Jutta Hofmann, Fiona Glassman, Eileen Rogers, Michaela Praus & Mikhail A Rojavin. (2022) Systemic IgG exposure and safety in patients with primary immunodeficiency: a randomized crossover study comparing a novel investigational wearable infusor versus the Crono pump. Immunotherapy 14:16, pages 1315-1328.
Crossref
Crossref
Amanda M. Kibbons, Ryan Moore, Leena Choi, Megan Peter & Autumn D. Zuckerman. (2022) Individual and Community-Level Characteristics and Adherence to Specialty Medications. Journal of Pharmacy Practice, pages 089719002211319.
Crossref
Crossref
Esin TEMELOĞLU ŞEN, H. Özlem SERTEL BERK & Dilsad SİNDEL. (2022) Ankilozan Spondilit ve Romatoid Artrit Hastalarının Sosyodemografik ve Klinik Değişkenlere Göre İlaç Uyumları: Betimsel bir çalışmaMedication Adherence of Patients with Ankylosing Spondylitis and Rheumatoid Arthritis by Sociodemographic Variables and Clinical Properties: A Descriptive Study. Health Care Academician Journal.
Crossref
Crossref
Wenhua Wang, Songyan Zheng & Jinjiang Li. (2022) Adsorption of lysozyme and antibodies at material surfaces: Implications to material compatibility for development of biologics. Journal of Drug Delivery Science and Technology 73, pages 103416.
Crossref
Crossref
Liora Bik, Martijn B. A. van Doorn, Neill Boeijink, Medelyn Wennekers, Arne A. Meesters, Peter Bloemen, Merete Haedersdal & Albert Wolkerstorfer. (2022) Clinical endpoints of needle‐free jet injector treatment: An in depth understanding of immediate skin responses. Lasers in Surgery and Medicine 54:5, pages 693-701.
Crossref
Crossref
Ahad Sabet, Daniel S. Dickerson, Eugenia E. Kunina, Anna Lucia Buccarello & Joëlle Monnet. (2022) A Randomised Controlled Trial Comparing the Pharmacokinetics and Tolerability of the Proposed Adalimumab Biosimilar MSB11022 Delivered via Autoinjector and Pre-filled Syringe in Healthy Subjects. Rheumatology and Therapy 9:2, pages 693-704.
Crossref
Crossref
Sara Eileen Meyer, Juliana Rachel Hoeper, Jens Buchholz & Dirk Meyer-Olson. (2022) Technische Alltagshilfen in der Rheumatologie – Was ist
sinnvoll, was ist bewiesen, welche Perspektiven gibt es?. Aktuelle Rheumatologie 47:01, pages 33-42.
Crossref
Crossref
Beate Bittner & Johannes Schmidt. 2022. Formulation and Device Lifecycle Management of Biotherapeutics. Formulation and Device Lifecycle Management of Biotherapeutics
1
46
.
Larry R. Brown. 2022. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
1
27
.
Sergey N. Avdeev, Alexandr V. Emelyanov, Oksana M. Kurbacheva, Irina M. Marusenko, Pavel I. NovikovOlga A. Rizakhanova & Larisa V. Shul’zhenko. (2021) A new delivery device for benralizumab (autoinjector, pen-injector device) in the clinical practice of treating severe eosinophilic asthma: Conclusion of the Expert Council. PULMONOLOGIYA 31:6, pages 776-781.
Crossref
Crossref
S. Pirri, R. Talarico, D. Marinello, G. Turchetti & M. Mosca. (2021) A systematic literature review of existing tools used to assess medication adherence in connective tissue diseases: the state of the art for the future development of co-designed measurement tools. Reumatismo 73:3.
Crossref
Crossref
A. Prieto Martín, J. Barbarroja Escudero, S. Haro Girón & A. Pérez Gómez. (2021) Avances y perspectivas actuales en recursos y estrategias terapéuticas: fármacos biológicos. Medicine - Programa de Formación Médica Continuada Acreditado 13:33, pages 1882-1892.
Crossref
Crossref
Kirollos S Hanna, Eve M Segal, Ashley Barlow & Brooke Barlow. (2020) Clinical strategies for optimizing infusion center care through a pandemic. Journal of Oncology Pharmacy Practice 27:1, pages 165-179.
Crossref
Crossref
Beate Bittner & Johannes Schmidt. 2021. Drug Delivery Devices and Therapeutic Systems. Drug Delivery Devices and Therapeutic Systems
159
179
.
Veysel Kayser & Mouhamad Reslan. 2020. Biologics, Biosimilars, and Biobetters. Biologics, Biosimilars, and Biobetters
89
107
.
Farrah Pompilus, Anna Ciesluk, Sara Strzok, Valerie Ciaravino, Kristina Harris, Boglarka Szegvari, Irina Mountian, Sophie Cleanthous & Juliette Meunier. (2020) Development and psychometric evaluation of the assessment of self-injection questionnaire: an adaptation of the self-injection assessment questionnaire. Health and Quality of Life Outcomes 18:1.
Crossref
Crossref
Makoto Ito, Masahiro Kamata, Hideaki Uchida, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi & Yayoi Tada. (2020) Introduction of self-injection increases compliance with dupilumab administration in adult patients with atopic dermatitis: A single-center retrospective study. JAAD International 1:2, pages 91-92.
Crossref
Crossref
Anja St Clair-Jones, Francesca Prignano, Joao Goncalves, Muriel Paul & Philipp Sewerin. (2020) Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review. Rheumatology and Therapy 7:4, pages 741-757.
Crossref
Crossref
Naceur Rekaya, Steven M. Vicik, Bors T. Hulesch & Laura L. McDonald. (2020) Enhancement of an Auto-Injector Device for Self-Administration of Etanercept in Patients With Rheumatoid Arthritis Confers Emotional and Functional Benefits. Rheumatology and Therapy 7:3, pages 537-552.
Crossref
Crossref
Carlo Lombardi, Diego Bagnasco & Giovanni Passalacqua. (2020) Biological agents for severe asthma: the evolution of the at-home self-injection approach. Current Opinion in Allergy & Clinical Immunology 20:4, pages 421-427.
Crossref
Crossref
Christof Maucksch, Peer M. Aries, Silke Zinke & Ulf Müller-Ladner. (2020) Patient Satisfaction with the Etanercept Biosimilar SB4 Device, Among Rheumatoid Arthritis and Spondyloarthropathy Patients - A German Observational Study. The Open Rheumatology Journal 14:1, pages 7-14.
Crossref
Crossref
Wanwisa Promsote, Megan E. DeMouth, Cassandra G. Almasri & Amarendra Pegu. (2020) Anti-HIV-1 Antibodies: An Update. BioDrugs 34:2, pages 121-132.
Crossref
Crossref
Kathryn Bailey, Irina Mountian, Richard Bruggraber, Kerri Sunderland, Nicola Tilt & Boglarka Szegvari. (2020) Patient Satisfaction with CIMZIA® (Certolizumab Pegol) AutoClicks® in the UK. Advances in Therapy 37:4, pages 1522-1535.
Crossref
Crossref
Carlo Lombardi, Giovanni Passalacqua & Diego Bagnasco. (2019) Severe asthma, biologicals, and auto‐injection: Yes, no, may be!. Allergy 75:2, pages 444-445.
Crossref
Crossref
jinjiang Li, Wenhua Wang & Songyan Zheng. (2022) Adsorption of Lysozyme and Antibodies at Material Surfaces: Implications to Material Compatibility for Development of Biologics. SSRN Electronic Journal.
Crossref
Crossref